<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39194579</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-7737</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Biology</Title><ISOAbbreviation>Biology (Basel)</ISOAbbreviation></Journal><ArticleTitle>Effect of Probiotic Fermented Milk Supplementation on Glucose and Lipid Metabolism Parameters and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">641</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biology13080641</ELocationID><Abstract><AbstractText>Modulating gut microbiota composition through probiotic administration has been proposed as a novel therapy for type 2 diabetes mellitus (T2DM), and fermented milk is arguably the most common and ideal probiotic carrier. The present meta-analysis was performed to assess the effects of probiotic fermented milk supplementation on glucose and lipid metabolism parameters and inflammatory markers in patients with T2DM using published data from randomized controlled trials (RCTs). The PubMed, Web of Science, and Cochrane Library databases were searched for relevant RCTs. A random-effects model was used to generate the weighted mean difference (WMD) and 95% confidence interval (95% CI). Probiotic fermented milk supplementation reduced the levels of fasting plasma glucose (MD = -17.01, 95% CI -26.43, -7.58 mg/dL; n = 7), hemoglobin A1c (MD = -0.47, 95% CI -0.74, -0.21%; n = 7), total cholesterol (MD = -5.15, 95% CI -9.52, -0.78 mg/dL; n = 7), and C-reactive protein (MD = -0.25, 95% CI -0.43, -0.08; n = 3) but did not significantly affect the levels of HOMA-IR (MD = -0.89, 95% CI -2.55, 0.78; n = 3), triglyceride (MD = -4.69, 95% CI -14.67, 5.30 mg/dL; n = 6), low-density lipoprotein cholesterol (MD = -4.25, 95% CI -8.63, 0.13 mg/dL; n = 7), high-density lipoprotein cholesterol (MD = 1.20, 95% CI -0.96, 3.36 mg/dL; n = 7), and tumor necrosis factor-alpha (MD: -0.58, 95% CI -1.47, 0.32 pg/mL; n = 2). In summary, the present findings provide a crude indication of the potential benefits of probiotic fermented milk supplementation in improving glucose and lipid metabolism and inflammation in patients with T2DM. However, more robust evidence is needed to determine the clinical significance of probiotic fermented milk in the management of T2DM.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Medicine, Nankai University, Tianjin 310071, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ningbo Yufangtang Biotechnology Co., Ltd., Ningbo 315012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lingmiao</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Fuhuai</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ningbo Yufangtang Biotechnology Co., Ltd., Ningbo 315012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Yongqiu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Ningbo Yufangtang Biotechnology Co., Ltd., Ningbo 315012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Feifei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ningbo Yufangtang Biotechnology Co., Ltd., Ningbo 315012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hidayat</LastName><ForeName>Khemayanto</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Suzhou Medical College of Soochow University, Suzhou 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yunhong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-7859-7482</Identifier><AffiliationInfo><Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Suzhou Medical College of Soochow University, Suzhou 215123, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022M721715</GrantID><Agency>China Postdoctoral Science Foundation</Agency><Country /></Grant><Grant><GrantID>KF-2023014</GrantID><Agency>Key Laboratory of Tropical Fruits and Vegetables Quality and Safety for State Market Regulation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biology (Basel)</MedlineTA><NlmUniqueID>101587988</NlmUniqueID><ISSNLinking>2079-7737</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood glucose</Keyword><Keyword MajorTopicYN="N">fermented milk</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">probiotic</Keyword></KeywordList><CoiStatement>Author H.Z. is a postdoctor on-the-job in the company Ningbo Yufangtang Biotechnology Co., Ltd. Author F.J., Y.Y. and F.X. was employed by the company Ningbo Yufangtang Biotechnology Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>10</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39194579</ArticleId><ArticleId IdType="pmc">PMC11351427</ArticleId><ArticleId IdType="doi">10.3390/biology13080641</ArticleId><ArticleId IdType="pii">biology13080641</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Diabetes Association Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2014;37:S81–S90. doi: 10.2337/dc14-S081.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc14-S081</ArticleId><ArticleId IdType="pubmed">24357215</ArticleId></ArticleIdList></Reference><Reference><Citation>Wnuk K., Świtalski J., Tatara T., Miazga W., Jopek S., Augustynowicz A., Religioni U., Gujski M. Workplace Interventions for Type 2 Diabetes Mellitus Prevention-an Umbrella Review. Curr. Diabetes Rep. 2023;23:293–304. doi: 10.1007/s11892-023-01521-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-023-01521-3</ArticleId><ArticleId IdType="pmc">PMC10520112</ArticleId><ArticleId IdType="pubmed">37728724</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Saeedi P., Karuranga S., Pinkepank M., Ogurtsova K., Duncan B.B., Stein C., Basit A., Chan J.C.N., Mbanya J.C., et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2021.109119</ArticleId><ArticleId IdType="pmc">PMC11057359</ArticleId><ArticleId IdType="pubmed">34879977</ArticleId></ArticleIdList></Reference><Reference><Citation>Athyros V.G., Doumas M., Imprialos K.P., Stavropoulos K., Georgianou E., Katsimardou A., Karagiannis A. Diabetes and lipid metabolism. Hormones. 2018;17:61–67. doi: 10.1007/s42000-018-0014-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42000-018-0014-8</ArticleId><ArticleId IdType="pubmed">29858856</ArticleId></ArticleIdList></Reference><Reference><Citation>Hidayat K., Du X., Shi B.M. Milk in the prevention and management of type 2 diabetes: The potential role of milk proteins. Diabetes/Metab. Res. Rev. 2019;35:e3187. doi: 10.1002/dmrr.3187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3187</ArticleId><ArticleId IdType="pubmed">31111646</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg R.B. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J. Clin. Endocrinol. Metab. 2009;94:3171–3182. doi: 10.1210/jc.2008-2534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2008-2534</ArticleId><ArticleId IdType="pubmed">19509100</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Ley S.H., Hu F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018;14:88–98. doi: 10.1038/nrendo.2017.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2017.151</ArticleId><ArticleId IdType="pubmed">29219149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurung M., Li Z., You H., Rodrigues R., Jump D.B., Morgun A., Shulzhenko N. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020;51:102590. doi: 10.1016/j.ebiom.2019.11.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.051</ArticleId><ArticleId IdType="pmc">PMC6948163</ArticleId><ArticleId IdType="pubmed">31901868</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Sun B., Yu D., Zhu C. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus. Front. Cell. Infect. Microbiol. 2022;12:834485. doi: 10.3389/fcimb.2022.834485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.834485</ArticleId><ArticleId IdType="pmc">PMC8886906</ArticleId><ArticleId IdType="pubmed">35242721</ArticleId></ArticleIdList></Reference><Reference><Citation>Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761–1772. doi: 10.2337/db06-1491.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db06-1491</ArticleId><ArticleId IdType="pubmed">17456850</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorshidian N., Yousefi M., Mortazavian A.M. Fermented milk: The most popular probiotic food carrier. Adv. Food Nutr. Res. 2020;94:91–114. doi: 10.1016/bs.afnr.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.afnr.2020.06.007</ArticleId><ArticleId IdType="pubmed">32892839</ArticleId></ArticleIdList></Reference><Reference><Citation>Tompkins T.A., Mainville I., Arcand Y. The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract. Benef. Microbes. 2011;2:295–303. doi: 10.3920/bm2011.0022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/bm2011.0022</ArticleId><ArticleId IdType="pubmed">22146689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B., Tachon S., Eigenheer R.A., Phinney B.S., Marco M.L. Lactobacillus casei Low-Temperature, Dairy-Associated Proteome Promotes Persistence in the Mammalian Digestive Tract. J. Proteome Res. 2015;14:3136–3147. doi: 10.1021/acs.jproteome.5b00387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.5b00387</ArticleId><ArticleId IdType="pubmed">26148687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranadheera C.S., Vidanarachchi J.K., Rocha R.S., Cruz A.G., Ajlouni S. Probiotic Delivery through Fermentation: Dairy vs. Non-Dairy Beverages. Fermentation. 2017;3:67. doi: 10.3390/fermentation3040067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/fermentation3040067</ArticleId></ArticleIdList></Reference><Reference><Citation>Barengolts E., Smith E.D., Reutrakul S., Tonucci L., Anothaisintawee T. The Effect of Probiotic Yogurt on Glycemic Control in Type 2 Diabetes or Obesity: A Meta-Analysis of Nine Randomized Controlled Trials. Nutrients. 2019;11:671. doi: 10.3390/nu11030671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11030671</ArticleId><ArticleId IdType="pmc">PMC6471569</ArticleId><ArticleId IdType="pubmed">30897796</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., Moher D., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. Bmj. 2021;372:n160. doi: 10.1136/bmj.n160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n160</ArticleId><ArticleId IdType="pmc">PMC8005925</ArticleId><ArticleId IdType="pubmed">33781993</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Altman D.G., Gøtzsche P.C., Jüni P., Moher D., Oxman A.D., Savovic J., Schulz K.F., Weeks L., Sterne J.A. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Alihosseini N., Moahboob S.A., Farrin N., Mobasseri M., Taghizadeh A., Ostadrahimi A.R. Effect of probiotic fermented milk (kefir) on serum level of insulin and homocysteine in type 2 diabetes patients. Acta Endocrinol. 2017;13:431–436. doi: 10.4183/aeb.2017.431.</Citation><ArticleIdList><ArticleId IdType="doi">10.4183/aeb.2017.431</ArticleId><ArticleId IdType="pmc">PMC6516555</ArticleId><ArticleId IdType="pubmed">31149212</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayat A., Azizi-Soleiman F., Heidari-Beni M., Feizi A., Iraj B., Ghiasvand R., Askari G. Effect of Cucurbita ficifolia and Probiotic Yogurt Consumption on Blood Glucose, Lipid Profile, and Inflammatory Marker in Type 2 Diabetes. Int. J. Prev. Med. 2016;7:30. doi: 10.4103/2008-7802.175455.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2008-7802.175455</ArticleId><ArticleId IdType="pmc">PMC4763470</ArticleId><ArticleId IdType="pubmed">26955460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 2012;28:539–543. doi: 10.1016/j.nut.2011.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2011.08.013</ArticleId><ArticleId IdType="pubmed">22129852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V., Akbarian-Moghari A. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J. Dairy Sci. 2011;94:3288–3294. doi: 10.3168/jds.2010-4128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3168/jds.2010-4128</ArticleId><ArticleId IdType="pubmed">21700013</ArticleId></ArticleIdList></Reference><Reference><Citation>Hove K.D., Brons C., Faerch K., Lund S.S., Rossing P., Vaag A. Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: A randomised double-blind placebo-controlled study. Eur. J. Endocrinol. 2015;172:11–20. doi: 10.1530/eje-14-0554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/eje-14-0554</ArticleId><ArticleId IdType="pubmed">25300285</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirjalili M., Salari Sharif A., Sangouni A.A., Emtiazi H., Mozaffari-Khosravi H. Effect of probiotic yogurt consumption on glycemic control and lipid profile in patients with type 2 diabetes mellitus: A randomized controlled trial. Clin. Nutr. ESPEN. 2023;54:144–149. doi: 10.1016/j.clnesp.2023.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2023.01.014</ArticleId><ArticleId IdType="pubmed">36963856</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamadshahi M., Veissi M., Haidari F., Javid A.Z., Mohammadi F., Shirbeigi E. Effects of probiotic yogurt consumption on lipid profile in type 2 diabetic patients: A randomized controlled clinical trial. J. Res. Med. Sci. 2014;19:531–536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4155708</ArticleId><ArticleId IdType="pubmed">25197295</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamadshahi M., Veissi M., Haidari F., Shahbazian H., Kaydani G.-A., Mohammadi F. Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes. BioImpacts BI. 2014;4:83–88. doi: 10.5681/bi.2014.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.5681/bi.2014.007</ArticleId><ArticleId IdType="pmc">PMC4097976</ArticleId><ArticleId IdType="pubmed">25035851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostadrahimi A., Taghizadeh A., Mobasseri M., Farrin N., Payahoo L., Gheshlaghi Z.B., Vahedjabbari M. Effect of Probiotic Fermented Milk (Kefir) on Glycemic Control and Lipid Profile In Type 2 Diabetic Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Iran. J. Public Health. 2015;44:228–237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4401881</ArticleId><ArticleId IdType="pubmed">25905057</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonucci L.B., dos Santos K.M.O., de Oliveira L.L., Ribeiro S.M.R., Martino H.S.D. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clin. Nutr. 2017;36:85–92. doi: 10.1016/j.clnu.2015.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2015.11.011</ArticleId><ArticleId IdType="pubmed">26732026</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavi S.N., Saboori S., Asbaghi O. Effect of daily probiotic yogurt consumption on inflammation: A systematic review and meta-analysis of randomized Controlled Clinical trials. Obes. Med. 2020;18:10022. doi: 10.1016/j.obmed.2020.100221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.obmed.2020.100221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziaei R., Ghavami A., Khalesi S., Ghiasvand R., Mokari Yamchi A. The effect of probiotic fermented milk products on blood lipid concentrations: A systematic review and meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 2021;31:997–1015. doi: 10.1016/j.numecd.2020.12.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2020.12.023</ArticleId><ArticleId IdType="pubmed">33612379</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Dilidaxi D., Wu Y., Sailike J., Sun X., Nabi X.H. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice. Biomed. Pharmacother. 2020;125:109914. doi: 10.1016/j.biopha.2020.109914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.109914</ArticleId><ArticleId IdType="pubmed">32035395</ArticleId></ArticleIdList></Reference><Reference><Citation>Markowiak-Kopeć P., Śliżewska K. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome. Nutrients. 2020;12:1107. doi: 10.3390/nu12041107.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12041107</ArticleId><ArticleId IdType="pmc">PMC7230973</ArticleId><ArticleId IdType="pubmed">32316181</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wu Y., Sailike J., Sun X., Abuduwaili N., Tuoliuhan H., Yusufu M., Nabi X.-h. Fourteen composite probiotics alleviate type 2 diabetes through modulating gut microbiota and modifying M1/M2 phenotype macrophage in db/db mice. Pharmacol. Res. 2020;161:105150. doi: 10.1016/j.phrs.2020.105150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105150</ArticleId><ArticleId IdType="pubmed">32818655</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.A., Keogh J.B., Clifton P.M. Probiotics, prebiotics, synbiotics and insulin sensitivity. Nutr. Res. Rev. 2018;31:35–51. doi: 10.1017/s095442241700018x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s095442241700018x</ArticleId><ArticleId IdType="pubmed">29037268</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintarič M., Langerholc T. Probiotic Mechanisms Affecting Glucose Homeostasis: A Scoping Review. Life. 2022;12:1187. doi: 10.3390/life12081187.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12081187</ArticleId><ArticleId IdType="pmc">PMC9409775</ArticleId><ArticleId IdType="pubmed">36013366</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>